JPMorgan Chase & Co’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1
| Closed | -$1 | – | 6822 |
|
|
2025
Q1 | $1 | Hold |
1
| – | – | ﹤0.01% | 6398 |
|
|
2024
Q4 | $6 | Sell |
1
-2
| -67% | -$12 | ﹤0.01% | 6277 |
|
|
2024
Q3 | $42 | Buy |
+3
| New | +$42 | ﹤0.01% | 6081 |
|
|
2023
Q3 | – | Sell |
-20
| Closed | -$512 | – | 6687 |
|
|
2023
Q2 | $512 | Buy |
+20
| New | +$512 | ﹤0.01% | 5639 |
|
|
2022
Q2 | – | Sell |
-385
| Closed | -$31K | – | 5967 |
|
|
2022
Q1 | $31K | Buy |
385
+72
| +23% | +$5.8K | ﹤0.01% | 5167 |
|
|
2021
Q4 | $64K | Sell |
313
-83
| -21% | -$17K | ﹤0.01% | 4992 |
|
|
2021
Q3 | $128K | Buy |
396
+44
| +13% | +$14.2K | ﹤0.01% | 4601 |
|
|
2021
Q2 | $91K | Buy |
+352
| New | +$91K | ﹤0.01% | 4798 |
|